Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Rallybio (RLYB) Capital Expenditures (2023)

Rallybio's Capital Expenditures history spans 1 years, with the latest figure at $12000.0 for Q3 2023.

On a quarterly basis, Capital Expenditures changed N/A to $12000.0 in Q3 2023 year-over-year; TTM through Dec 2024 was $12000.0, a 0.0% change, with the full-year FY2023 number at $12000.0, down 77.78% from a year prior.
Capital Expenditures hit $12000.0 in Q3 2023 for Rallybio.
Over the last five years, Capital Expenditures for RLYB hit a ceiling of $12000.0 in Q3 2023 and a floor of $12000.0 in Q3 2023.